25.78
price up icon1.54%   0.39
 
loading
Omnicell Inc stock is traded at $25.78, with a volume of 861.82K. It is up +1.54% in the last 24 hours and down -21.14% over the past month. Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$25.39
Open:
$25.7
24h Volume:
861.82K
Relative Volume:
1.37
Market Cap:
$1.46B
Revenue:
$1.08B
Net Income/Loss:
$-20.76M
P/E Ratio:
-56.04
EPS:
-0.46
Net Cash Flow:
$151.63M
1W Performance:
-17.27%
1M Performance:
-21.14%
6M Performance:
-48.58%
1Y Performance:
-14.78%
1-Day Range:
Value
$25.44
$26.25
1-Week Range:
Value
$22.66
$31.03
52-Week Range:
Value
$22.66
$55.74

Omnicell Inc Stock (OMCL) Company Profile

Name
Name
Omnicell Inc
Name
Phone
(877) 415-9990
Name
Address
4220 NORTH FREEWAY, FORT WORTH
Name
Employee
3,670
Name
Twitter
@Omnicell
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
OMCL's Discussions on Twitter

Compare OMCL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Health Information Services icon
OMCL
Omnicell Inc
25.78 1.46B 1.08B -20.76M 151.63M -0.46
Health Information Services icon
VEEV
Veeva Systems Inc
237.05 38.54B 2.75B 714.14M 1.09B 4.33
Health Information Services icon
DOCS
Doximity Inc
59.19 11.13B 516.85M 174.11M 217.38M 0.87
Health Information Services icon
TEM
Tempus Ai Inc
61.37 9.87B 640.44M -743.28M -206.93M -11.29
Health Information Services icon
HQY
Healthequity Inc
90.40 7.83B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
40.01 7.04B 906.14M -52.62M 89.62M -0.3621

Omnicell Inc Stock (OMCL) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-31-24 Downgrade BofA Securities Buy → Neutral
Aug-02-24 Upgrade Barclays Underweight → Equal Weight
Jan-03-24 Initiated Barclays Underweight
Nov-03-23 Downgrade BTIG Research Buy → Neutral
Nov-03-23 Upgrade Piper Sandler Neutral → Overweight
Nov-03-23 Upgrade Wells Fargo Underweight → Equal Weight
Oct-11-23 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Sep-26-23 Reiterated Wells Fargo Underweight
Aug-02-23 Downgrade Piper Sandler Overweight → Neutral
Jul-20-23 Downgrade Wells Fargo Overweight → Underweight
Feb-27-23 Upgrade The Benchmark Company Hold → Buy
Nov-03-22 Downgrade The Benchmark Company Buy → Hold
Sep-16-22 Initiated KeyBanc Capital Markets Overweight
Sep-09-22 Initiated BofA Securities Buy
Jul-15-22 Initiated SVB Leerink Mkt Perform
Dec-06-21 Resumed Wells Fargo Overweight
Jun-09-21 Initiated JP Morgan Neutral
May-24-21 Initiated BTIG Research Buy
Feb-02-21 Upgrade Piper Sandler Neutral → Overweight
Dec-08-20 Initiated Berenberg Buy
Dec-03-20 Downgrade Cantor Fitzgerald Overweight → Neutral
Jul-07-20 Initiated Stephens Overweight
Feb-07-20 Reiterated Dougherty & Company Buy
Nov-21-19 Reiterated Dougherty & Company Buy
Jul-26-19 Upgrade Craig Hallum Hold → Buy
Mar-07-19 Reiterated Dougherty & Company Buy
Jun-29-18 Resumed The Benchmark Company Buy
Sep-05-17 Reiterated The Benchmark Company Buy
Jul-28-17 Reiterated Dougherty & Company Buy
Apr-21-17 Downgrade Piper Jaffray Overweight → Neutral
Jan-19-17 Initiated Dougherty & Company Buy
Dec-06-16 Reiterated The Benchmark Company Buy
Jul-07-16 Reiterated FBR Capital Outperform
Mar-21-16 Reiterated Topeka Capital Markets Buy
Jan-07-16 Initiated The Benchmark Company Buy
Nov-16-15 Reiterated Topeka Capital Markets Buy
Oct-30-15 Reiterated FBR Capital Outperform
Sep-28-15 Upgrade Sidoti Neutral → Buy
Jul-31-15 Reiterated Topeka Capital Markets Buy
View All

Omnicell Inc Stock (OMCL) Latest News

pulisher
May 09, 2025

Remote Dispenser Market Grows with Automation Trends - openPR.com

May 09, 2025
pulisher
May 09, 2025

US$38.50: That's What Analysts Think Omnicell, Inc. (NASDAQ:OMCL) Is Worth After Its Latest Results - simplywall.st

May 09, 2025
pulisher
May 09, 2025

Healthcare Robotics Market Generated Opportunities, Future - openPR.com

May 09, 2025
pulisher
May 09, 2025

Omnicell Q1 Earnings & Revenues Beat, '25 EPS View Down, Stock Up - MSN

May 09, 2025
pulisher
May 07, 2025

Omnicell, Inc. (NASDAQ:OMCL) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025
pulisher
May 07, 2025

Benchmark cuts Omnicell stock price target to $40 from $62 By Investing.com - Investing.com South Africa

May 07, 2025
pulisher
May 07, 2025

Beyond The Numbers: 4 Analysts Discuss Omnicell Stock - Benzinga

May 07, 2025
pulisher
May 07, 2025

OMNICELL, INC. SEC 10-Q Report - TradingView

May 07, 2025
pulisher
May 07, 2025

Benchmark cuts Omnicell stock price target to $40 from $62 - Investing.com Australia

May 07, 2025
pulisher
May 07, 2025

Omnicell: Facing New Headwinds (NASDAQ:OMCL) - Seeking Alpha

May 07, 2025
pulisher
May 07, 2025

Benchmark Lowers Price Target for Omnicell (OMCL) to $40 | OMCL Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Omnicell (OMCL) Price Target Lowered by Wells Fargo | OMCL Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Omnicell (OMCL) Price Target Reduced Amid Tariff Concerns | OMCL Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Omnicell (OMCL) Price Target Reduced by BofA Analyst Amid Tariff Concerns | OMCL Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Omnicell (OMCL) Price Target Slashed Amid Tariff Concerns | OMCL Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Omnicell First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Omnicell Reports Strong Q1 2025 Financial Results - TipRanks

May 07, 2025
pulisher
May 07, 2025

Omnicell Inc (OMCL) Q1 2025 Earnings Call Highlights: Navigating Tariff Challenges and Revenue ... - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Omnicell Inc (OMCL) Q1 2025 Earnings Call Highlights: Navigating Tariff Challenges and Revenue Growth - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Omnicell Inc (OMCL) Q1 2025 Earnings Call Highlights: Navigating Tariff Challenges and Revenue ... By GuruFocus - Investing.com Canada

May 07, 2025
pulisher
May 06, 2025

Omnicell Q1 2025 Earnings Call Transcript - MarketBeat

May 06, 2025
pulisher
May 06, 2025

Omnicell outlines $40M tariff impact and anticipates $1.105B-$1.155B revenue for 2025 - MSN

May 06, 2025
pulisher
May 06, 2025

Omnicell: Q1 Earnings Snapshot - Midland Daily News

May 06, 2025
pulisher
May 06, 2025

Why Omnicell (OMCL) Shares Are Trading Lower Today - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

Earnings call transcript: Omnicell Q1 2025 beats EPS forecasts, stock drops - Investing.com Nigeria

May 06, 2025
pulisher
May 06, 2025

Relative Strength Alert For Omnicell - Nasdaq

May 06, 2025
pulisher
May 06, 2025

Omnicell falls after 2025 profit forecast cut - TradingView

May 06, 2025
pulisher
May 06, 2025

Omnicell Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 06, 2025
pulisher
May 06, 2025

Omnicell Announces First Quarter 2025 Results - 01net

May 06, 2025
pulisher
May 06, 2025

Omnicell (OMCL) Beats Q1 Expectations, Revises 2025 Guidance - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Omnicell Q1 2025 slides: revenue up 10%, recurring revenue reaches 56% of total - Investing.com Australia

May 06, 2025
pulisher
May 06, 2025

Omnicell Q1 2025 slides: revenue up 10%, recurring revenue reaches 56% of total By Investing.com - Investing.com South Africa

May 06, 2025
pulisher
May 06, 2025

Omnicell (OMCL) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

Omnicell (OMCL) Adjusts 2025 Guidance Amid Cost Concerns | OMCL Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Omnicell (OMCL) Surpasses Q1 Revenue Expectations with $270M | O - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Omnicell Inc Surpasses Q1 2025 Estimates with $0.26 EPS and $270 Million Revenue - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Omnicell Announces First Quarter 2025 Results | OMCL Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Omnicell shares tumble on weak guidance despite Q1 beat By Investing.com - Investing.com South Africa

May 06, 2025
pulisher
May 06, 2025

Omnicell shares tumble on weak guidance despite Q1 beat - Investing.com Australia

May 06, 2025
pulisher
May 06, 2025

(OMCL) OMNICELL INC. Forecasts Fiscal Year 2025 Adjusted EPS Range $1.00$1.65 - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

(OMCL) OMNICELL INC. Forecasts Q2 Adjusted EPS Range $0.19$0.32 - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

Earnings Flash (OMCL) OMNICELL INC. Reports Q1 Revenue $269.7M, vs. FactSet Est of $259.9M - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

Omnicell, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 06, 2025
pulisher
May 05, 2025

Omnicell (OMCL) Q1 Earnings Report Preview: What To Look For - Yahoo Finance

May 05, 2025
pulisher
May 02, 2025

Multifunctional Intravenous Drug Dispensing Robot Market - openPR.com

May 02, 2025
pulisher
May 02, 2025

Central Fill Pharmacy Automation Market Is Booming So - openPR.com

May 02, 2025
pulisher
Apr 29, 2025

Central Fill Pharmacy Automation Market Set to Witness - openPR.com

Apr 29, 2025
pulisher
Apr 28, 2025

Why Omnicell (OMCL) is a Top Value Stock for the Long-Term - Yahoo Finance

Apr 28, 2025
pulisher
Apr 28, 2025

Is The Market Rewarding Omnicell, Inc. (NASDAQ:OMCL) With A Negative Sentiment As A Result Of Its Mixed Fundamentals? - simplywall.st

Apr 28, 2025

Omnicell Inc Stock (OMCL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Omnicell Inc Stock (OMCL) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
PARRISH MARK W
Director
Dec 10 '24
Sale
47.30
12,000
567,638
58,427
$23.91
price up icon 0.13%
$23.07
price down icon 0.99%
$11.98
price up icon 0.93%
$25.02
price down icon 0.20%
$22.82
price up icon 1.33%
health_information_services WAY
$40.01
price down icon 1.19%
Cap:     |  Volume (24h):